FrancophonIA/ELRC3.0 huggingface dataset:
English: In use shelf life: from a microbiological point of view, the product should be used immediately after dilution.
Danish: Holdbarhed ved brug: Ud fra et mikrobiologisk synspunkt, bør præparatet anvendes umiddelbart efter fortynding.
English: A retrospective assessment of pharmacokinetic interactions in children and adolescents with epilepsy (4 to 17 years) confirmed that adjunctive therapy with orally administered levetiracetam did not influence the steady-state serum concentrations of concomitantly administered carbamazepine and valproate.
Danish: En retrospektiv vurdering af farmakokinetiske interaktioner hos børn og unge (4 til 17 år) med epilepsi bekræftede, at tillægsbehandling med oralt administreret levetiracetam ikke havde indflydelse på steady state-serumkoncentrationer af samtidigt administreret carbamazepin og valproat.
English: Should your doctor decide to stop your Levetiracetam SUN treatment, he/she will instruct you about the gradual withdrawal of Levetiracetam SUN.
Danish: Hvis lægen beslutter at stoppe Deres behandling med Levetiracetam SUN, vil han/hun instruere Dem i, hvordan De gradvist skal ophøre med at bruge Levetiracetam SUN.
English: In a pooled analysis, the percentage of patients who achieved 50% or greater reduction from baseline in the partial onset seizure frequency per week at stable dose (12/14 weeks) was of 27.7%, 31.6% and 41.3% for patients on 1000, 2000 or 3000 mg levetiracetam respectively and of 12.6% for patients on placebo.
Danish: I en sammenfattende analyse var den procentdel af patienterne, som opnåede 50 % eller større reduktion fra baseline i frekvensen af partielle anfald pr. uge ved stabil dosis (12/14 uger), 27,7 %, 31,6 % og 41,3 % for patienter, som fik hhv. 1.000, 2.000 eller 3.000 mg levetiracetam, og 12,6 % for patienter, som fik placebo.
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Danish: Yderligere oplysninger om dette lægemiddel findes på Det Europæiske Lægemiddelagenturs hjemmeside: http://www.ema.europa.eu.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Box of 10 vials
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Æske med 10 hætteglas
English: This binding site is the synaptic vesicle protein 2A, believed to be involved in vesicle fusion and neurotransmitter exocytosis.
Danish: Dette bindingssted er det synaptiske vesikelprotein 2A, som formodes at være involveret i vesikelfusion og eksocytose af neurotransmittere.
English: Somnolence, agitation, aggression, depressed level of consciousness, respiratory depression and coma were observed with levetiracetam overdoses.
Danish: Døsighed, agitation, aggression, nedsat bevidsthedsniveau, repirationshæmning og koma blev set ved overdosering med levetiracetam.
English: However, based on the pharmacokinetic characteristics of levetiracetam, the pharmacokinetics in adults after intravenous administration and the pharmacokinetics in children after oral administration, the exposure (AUC) of levetiracetam is expected to be similar in paediatric patients aged 4 to 12 years after intravenous and oral administration.
Danish: Baseret på levetiracetams farmakokinetiske egenskaber er farmakokinetikken hos voksne efter intravenøs administration og farmakokinetikken hos børn efter oral administration tyder imidlertid på, at eksponeringen for levetiracetam (AUC) er den samme hos pædiatriske patienter fra 4 til 12 år efter intravenøs og oral administration.
English: The time independent pharmacokinetic profile of levetiracetam was also confirmed following 1500 mg intravenous infusion for 4 days with twice daily dosing.
Danish: Levetiracetams tidsuafhængige farmakokinetiske profil blev også bekræftet efter 1.500 mg intravenøs infusion i 4 dage med dosering 2 gange dagligt.
English: In vitro, levetiracetam and its primary metabolite have been shown not to inhibit the major human liver cytochrome P450 isoforms (CYP3A4, 2A6, 2C9, 2C19, 2D6, 2E1 and 1A2), glucuronyl transferase (UGT1A1 and UGT1A6) and epoxide hydroxylase activities.
Danish: In vitro-studier viste, at levetiracetam og dets primære metabolit ikke hæmmer aktiviteten af de vigtigste humane lever cytochrom P450 isoformer (CYP3A4, 2A6, 2C9, 2C19, 2D6, 2E1 og 1A2), glucuronyltransferase (UGT1A1 og UGT1A6) og epoxid hydroxylase.
English: If levetiracetam has to be discontinued it is recommended to withdraw it gradually (e.g. in adults and adolescents weighing more than 50 kg: 500 mg decreases twice daily every two to four weeks; in children and adolescents weighting less than 50 kg: dose decrease should not exceed 10 mg/kg twice daily every two weeks).
Danish: Hvis behandlingen med levetiracetam skal afbrydes, anbefales det at seponere gradvist (f.eks. for voksne og unge, som vejer mere end 50 kg: reduktion med 500 mg to gange dagligt hver anden til fjerde uge; for børn og unge, som vejer under 50 kg: dosis bør ikke reduceres med mere end 10 mg/kg to gange dagligt).
English: This medicinal product is for single use only, any unused solution should be discarded.
Danish: Lægemidlet er kun til enkeltdosisbrug, ubrugt opløsning skal destrueres.
English: Levetiracetam SUN is packed in colorless tubular glass vial (type I) with 20 mm grey bromobutyl rubber stopper sealed with white flip-top aluminum seal.
Danish: Levetiracetam SUN er emballeret i farveløse, cylindriske hætteglas (type I) med en 20 mm grå brombutylgummiprop, som er forseglet med en hvid flip-top hætte af aluminium.
English: Oral contraceptives and other pharmacokinetics interactions Levetiracetam 1,000 mg daily did not influence the pharmacokinetics of oral contraceptives (ethinylestradiol and levonorgestrel); endocrine parameters (luteinizing hormone and progesterone) were not modified.
Danish: Orale kontraceptiva og andre farmakokinetiske interaktioner Levetiracetam 1.000 mg dagligt påvirker ikke farmakokinetikken af orale kontraceptiva (ethinylestradiol og levonorgestrel); endokrine parametre (luteiniserende hormon og progesteron) blev ikke ændret.
English: For children with renal impairment, levetiracetam dose needs to be adjusted based on the renal function as levetiracetam clearance is related to renal function.
Danish: Hos børn med nedsat nyrefunktion skal levetiracetam-dosis justeres i forhold til nyrefunktionen, da levetiracetamclearance afhænger af nyrefunktionen.
English: - If you notice any slow down in growth, or if there is unexpected puberty development in your child, please contact your doctor.
Danish: - Kontakt Deres læge, hvis De bemærker en stagnation i væksten, eller hvis der opstår uventet pubertetsudvikling hos Deres barn.
English: Adjustment of the dose is recommended in elderly patients with compromised renal function (see "Renal impairment" below).
Danish: Dosisjustering anbefales hos ældre patienter med nedsat nyrefunktion (se “Nedsat nyrefunktion” nedenfor).
English: The intravenous administration of doses up to 4000 mg diluted in 100 ml of 0.9% sodium chloride infused over 15 minutes and doses up to 2500 mg diluted in 100 ml of 0.9% sodium chloride infused over 5 minutes was evaluated.
Danish: Intravenøs administration af doser op til 4.000 mg fortyndet i 100 ml 0,9 % natriumchlorid infunderet i løbet af 15 minutter og doser op til 2.500 mg fortyndet i 100 ml 0,9 % natriumchlorid infunderet i løbet af 5 minutter blev evalueret.
English: Probenecid (500 mg four times daily), a renal tubular secretion blocking agent, has been shown to inhibit the renal clearance of the primary metabolite but not of levetiracetam.
Danish: Det er påvist, at probenecid (500 mg fire gange dagligt), en substans som blokerer den tubulære sekretion i nyrerne, hæmmer renal udskillelse af den primære metabolit men ikke af levetiracetam.
English: From 50 kg(2)
Danish: Fra 50 kg (2)
English: Production of the primary metabolite, ucb L057, is not supported by liver cytochrome P450 isoforms.
Danish: Dannelse af den primære metabolit, ucb L057 er ikke afhængig af CYP-isozymer.
English: The CLcr in ml/min/1.73 m2 may be estimated from serum creatinine (mg/dl) determination using, for young adolescents and children using the following formula (Schwartz formula):
Danish: CLcr i ml/min/1,73 m2 kan hos unge teenagere og børn beregnes ud fra serum-kreatinin (mg/dl) ved at anvende følgende formel (Schwartz formel):
English: (1) A 15 mg/kg (0.15 ml/kg) loading dose is recommended on the first day of treatment with levetiracetam.
Danish: (1) En støddosis på 15 mg/kg (0,15 ml/kg) anbefales på den første behandlingsdag med levetiracetam.
English: You should not drive or use machines until it is established that your ability to perform such activities is not affected.
Danish: De må ikke køre bil, motorcykel, cykle eller anvende maskiner, før De er helt sikker på, at Deres evne til at udføre sådanne aktiviteter ikke er påvirket.
English: Levetiracetam SUN is for intravenous use.
Danish: Levetiracetam SUN er til intravenøs anvendelse.
English: Levetiracetam can be used during pregnancy, only if after careful assessment it is considered necessary by your doctor.
Danish: Levetiracetam SUN må kun anvendes under graviditeten, hvis Deres læge efter omhyggelig vurdering mener, at det er nødvendigt.
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 500 mg/5 ml
Danish: INDHOLD ANGIVET SOM VÆGT, VOLUMEN ELLER ENHEDER 500 mg/5 ml
English: The recommended dose must be diluted in at least 100 ml of a compatible diluent and infused over 15 minutes.
Danish: Den anbefalede dosis skal fortyndes med mindst 100 ml forenelig fortyndingsvæske og infunderes i løbet af 15 minutter.
English: Levetiracetam SUN may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy.
Danish: Levetiracetam SUN kan påvirke Deres evne til at køre bil, motorcykel, cykle eller betjene værktøj og maskiner, da det kan give døsighed.
English: If stopping treatment, as with other antiepileptic medicines, Levetiracetam SUN should be discontinued gradually to avoid an increase of seizures.
Danish: Hvis De holder op med at bruge Levetiracetam SUN Ved ophør af behandling skal Levetiracetam SUN ligesom andre lægemidler mod epilepsi nedtrappes gradvist for at undgå en forøgelse af anfald.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vial of 5 ml
Danish: MINDSTEKRAV TIL MÆRKNING PÅ SMÅ INDRE EMBALLAGER Hætteglas med 5 ml
English: This medicinal product contains 2.5 mmol (or 57 mg) sodium per maximum single dose (0.8 mmol (or 19 mg) per vial).
Danish: Dette lægemiddel indeholder 2,5 mmol (eller 57 mg) natrium pr. maksimale enkeltdosis (0,8 mmol (19 mg) pr. hætteglas).
English: In man, an activity in both partial and generalised epilepsy conditions (epileptiform discharge/ photoparoxysmal response) has confirmed the broad spectrum pharmacological profile of levetiracetam.
Danish: (epileptiforme afladninger/fotoparoxysmalt respons) bekræftet den bredspektrede farmakologiske profil af levetiracetam.
English: Uncommon: may affect up to 1 in 100 people - decreased number of blood platelets, decreased number of white blood cells - weight decrease, weight increase - suicide attempt and suicidal ideation, mental disorder, abnormal behaviour, hallucination, anger,
Danish: Ikke almindelig: kan påvirke op til 1 ud af 100 - nedsat antal blodplader og hvide blodlegemer; - vægttab, vægtstigning; - selvmordsforsøg og selvmordstanker, mental ubalance, unormal adfærd, hallucinationer, vrede,
English: SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
Danish: EVENTUELLE SÆRLIGE FORHOLDSREGLER VED BORTSKAFFELSE AF IKKE ANVENDT LÆGEMIDDEL SAMT AFFALD HERA
English: Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily.
Danish: Afhængigt af klinisk respons og tolerabilitet kan den daglige dosis øges til 1.500 mg to gange dagligt.
English: necrolysis, Stevens-Johnson syndrome, erythema multiforme
Danish: Johnsons syndrom, erythema multiforme
English: Prevalence is significantly higher in Japanese patients when compared to non-Japanese patients.
Danish: Forekomsten er betydeligt højere hos patienter af japansk afstamning i forhold til patienter af ikke-japansk afstamning halten eller gangbesvær.
English: Method of administration
Danish: ADMINISTATIONSMETODE
English: At 3600 mg/kg/day, in only one of the 2 EFD studies, there was a slight decrease in foetal weight associated with a marginal increase in skeletal variations/minor anomalies.
Danish: Kun i ét af de to embryo-føtale udviklingsforsøg med 3.600 mg/kg/dag var der et lille fald i fostervægt forbundet med en marginal forøgelse af skeletale ændringer/mindre anomalier.
English: (2) Dose in children and adolescents 50 kg or more is the same as in adults.
Danish: (2) Dosis til børn og unge, som vejer 50 kg eller mere, er den samme som til voksne.
English: The recommended starting dose is 250 mg twice daily which should be increased to an initial therapeutic dose of 500 mg twice daily after two weeks.
Danish: Den anbefalede initialdosis er 250 mg to gange dagligt, som efter to uger øges til en initial terapeutisk dosis på 500 mg to gange dagligt.
English: Kubickiego 11 02-954 Warszawa Polska tel. +48 22 642 07 75
Danish: 02-954 Warszawa Polska tel. +48 22 642 07 75
English: Each carton contains 10 vials.
Danish: Hver pakning indeholder 10 hætteglas.
English: Peak plasma concentration (Cmax) observed in 17 subjects following a single intravenous dose of 1500 mg infused over 15 minutes was 51 ± 19 μg/mL (arithmetic average ± standard deviation).
Danish: Maksimal plasmakoncentration (Cmax) observeret hos 17 forsøgspersoner efter en intravenøs enkeltdosis på 1.500 mg infunderet i løbet af 15 minutter var 51 ± 19 µg/ml (aritmetisk middelværdi ± standardafvigelse).
English: In adults, levetiracetam efficacy has been demonstrated in 3 double-blind, placebo-controlled studies at 1000 mg, 2000 mg, or 3000 mg/day, given in 2 divided doses, with a treatment duration of up to 18 weeks.
Danish: Levetiracetams virkning hos voksne er blevet demonstreret i 3 dobbeltblinde placebokontrollerede studier med hhv. 1.000 mg, 2.000 mg eller 3.000 mg/dag, fordelt på to doser, med en behandlingsvarighed på op til 18 uger.
English: Abdominal pain, diarrhoea, dyspepsia, vomiting, nausea
Danish: Abdominalsmerter, diarré, dyspepsi, opkastning, nausea
English: If you get any side effects talk to your doctor or pharmacist.
Danish: Hvis De oplever bivirkninger, bør De tale med Deres læge, apotekspersonalet eller sygeplejersken.
English: A single dose of 1500 mg levetiracetam diluted in 100 ml of a compatible diluent and infused intravenously over 15 minutes is bioequivalent to 1500 mg levetiracetam oral intake, given as three 500 mg tablets.
Danish: En enkeltdosis på 1.500 mg levetiracetam fortyndet i 100 ml af en kompatibel fortyndingsvæske og infunderet intravenøst i løbet af 15 minutter er bioækvivalent med 1.500 mg levetiracetam indtaget oralt, givet som tre 500 mg tabletter.
English: Add-on therapy for children aged 4 to 11 years and adolescents (12 to 17 years) weighing less than 50 kg
Danish: Tillægsbehandling til børn i alderen 4 til 11 år og unge (12 til 17 år), som vejer mindre end 50 kg
English: Depression, hostility/ aggression, anxiety, insomnia, nervousness/irritability
Danish: Depression, fjendtlighed/aggres sion, angst, insomni, nervøsitet/ irritabilitet
English: In this study, levetiracetam dose was 3000 mg/day for adults and adolescents or 60 mg/kg/day for children, given in 2 divided doses.
Danish: I dette studie var levetiracetam-dosis 3.000 mg/dag for voksne og unge og 60 mg/kg/dag for børn, fordelt på 2 doser.
English: Completed suicide, personality disorder, thinking abnormal, delirium
Danish: Selvmord, personlighedsforstyr relse, abnorm tankegang, delirium
English: What you need to know before you are given Levetiracetam SUN
Danish: Det skal De vide, før De begynder at få Levetiracetam SUN
English: Table 1.
Danish: Tabe1 1.
English: A peri- and post-natal development study was performed in rats with levetiracetam doses of 70, 350 and 1800 mg/kg/day.
Danish: Der blev udført et peri- og postnatalt udviklingsforsøg med levetiracetam-doser på 70, 350 og 1.800 mg/kg/dag i rotter.
English: Dose Withdrawal Volume
Danish: Dosis Udtrækningsvolumen Volumen af fortyndingsvæske
English: PHARMACEUTICAL FORM AND CONTENTS 500 mg/5 ml
Danish: LÆGEMIDDELFORM OG INDHOLD (PAKNINGSSTØRRELSE) 500 mg/5 ml
English: Suicide attempt, suicidal ideation, psychotic disorder, abnormal behaviour, hallucination, anger, confusional state, panic attack, affectlability/mood swings, agitation
Danish: Selvmordsforsøg, selvmordstanker, psykose, unormal adfærd, hallucinationer, vrede, konfusion, panikanfald, affektlabilitet/humørsving ninger, agitation
English: Levetiracetam SUN contains sodium
Danish: Levetiracetam SUN indeholder natrium
English: Efficacy of levetiracetam as monotherapy was established in a double-blind, parallel group, noninferiority comparison to carbamazepine controlled release (CR) in 576 patients 16 years of age or older with newly or recently diagnosed epilepsy.
Danish: Levetiracetams virkning som monoterapi blev bestemt i et dobbeltblindt, ækvivalensstudie med parallelle grupper med carbamazepin-depottabletter (CR) hos 576 patienter over 16 år med ny eller nyligt diagnosticeret epilepsi.
English: One vial of Levetiracetam SUN concentrate contains 500 mg levetiracetam (5 ml concentrate of 100 mg/ml).
Danish: Et hætteglas med Levetiracetam SUN koncentrat indeholder 500 mg levetiracetam (5 ml koncentrat på 100 mg/ml).
English: Dose in adults and adolescents (from 16 years of age) When you will first start taking Levetiracetam SUN, your doctor will prescribe a lower dose for 2 weeks before adjusting the dose as necessary.
Danish: Når De begynder at bruge Levetiracetam SUN, vil Deres læge ordinere en lavere dosis i 2 uger, før der foretages de nødvendige justeringer af dosis.
English: - weakness, feel light-headed or dizzy or have difficulty breathing, as these may be signs of a serious allergic (anaphylactic) reaction - swelling of the face, lips, tongue and throat (Quincke's oedema) - flu-like symptoms and a rash on the face followed by an extended rash with a high temperature, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes (Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]) - symptoms such as low urine volume, tiredness, nausea, vomiting, confusion and swelling in the legs, ankles or feet, as this may be a sign of sudden decrease of kidney function - a skin rash which may form blisters and look like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme) - a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome) - a more severe form of rash causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis) - signs of serious mental changes or if someone around you notices signs of confusion, somnolence (sleepiness), amnesia (loss of memory), memory impairment (forgetfulness), abnormal behaviour or other neurological signs including involuntary or uncontrolled movements.
Danish: - svaghed, føler Dem ør i hovedet eller svimmel, eller har vejrtrækningsbesvær, da disse symptomer kan være tegn på en alvorlig allergisk (anafylaktisk) reaktion - hævelse af ansigt, læber, tunge eller svælg (Quinckes ødem) - influenzalignende symptomer og udslæt i ansigtet, som efterfølges af udbredt udslæt med feber, forhøjede leverenzymniveauer i blodprøver og et forhøjet antal af en bestemt type hvide blodlegemer (eosinofili) og forstørrede lymfekirtler (lægemiddelreaktion med eusinofili og systemiske reaktioner [DRESS]) - symptomer, såsom nedsat urinmængde, træthed, kvalme, opkastning, forvirring og hævelse af benene, anklerne eller fødderne, da disse kan være tegn på pludseligt nedsat nyrefunktion - et hududslæt, der kan danne blærer, og som ligner små skydeskiver (mørk plet i midten omgivet af et blegere område, med en mørk ring om kanten) (erythema multiforme) - et udbredt udslæt med blærer og skællende hud, især omkring munden, næsen, øjnene og kønsorganerne (Stevens-Johnson syndrom) - et mere alvorligt udslæt, der forårsager afskalning af huden på mere end 30 % af kropsoverfladen (toksisk epidermal nekrolyse) - tegn på alvorlige mentale forandringer, eller hvis nogen omkring Dem bemærker tegn på forvirring, somnolens (døsighed), amnesi (hukommelsestab), hukommelsessvækkelse (glemsomhed), unormal adfærd, eller andre neurologiske tegn, herunder ufrivillige eller ukontrollerede bevægelser.
English: Levetiracetam SUN concentrate is for intravenous use only and the recommended dose must be diluted in at least 100 ml of a compatible diluent and administered intravenously as a 15-minute intravenous infusion (see section 6.6).
Danish: Levetiracetam SUN-koncentrat er kun til intravenøs anvendelse, og den anbefalede dosis skal fortyndes i mindst 100 ml kompatibel opløsningsvæske og administreres intravenøst som en 15minutters intravenøs infusion (se pkt.
English: Common: may affect up to 1 in 10 people - anorexia (loss of appetite) - depression, hostility or aggression, anxiety, insomnia, nervousness or irritability - convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness),
Danish: Almindelig: kan påvirke op til 1 ud af 10 - appetitløshed; - depression, fjendtlighed eller aggression, angst, søvnløshed, nervøsitet eller irritabilitet; - kramper, problemer med at holde balancen, svimmelhed (følelse af usikker gang), letargi
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 100 mg of levetiracetam.
Danish: KVALITATIV OG KVANTITATIV SAMMENSÆTNING Hver ml indeholder 100 mg levetiracetam.
English: (2) Following dialysis, a 5 to 10 mg/kg (0.05 to 0.10 ml/kg) supplemental dose is recommended.
Danish: (2) Efter dialyse anbefales 5 til 10 mg/kg (0,05 til 0,10 ml/kg) som supplerende dosis.
English: CLcr (ml/min/1.73 m2) = -------------------------------- x 1.73
Danish: CLcr (ml/min/1,73 m2) = ----------------------------- x 1,73 Personens BSA (m2 )
English: Dosing adjustment for adult and adolescents patients weighing more than 50 kg with impaired renal function
Danish: Dosisjustering for voksne og unge patienter, der vejer mere end 50 kg, med nedsat nyrefunktion: Nyrefunktion
English: Since there was limited exposure for levetiracetam intravenous use and since oral and intravenous formulations are bioequivalent, the safety information of levetiracetam intravenous will rely on levetiracetam oral use.
Danish: SUN og da de orale formuleringer og den intravenøse formulering er bioækvivalente, beror sikkerhedsinformationen for intravenøst Levetiracetam SUN på Levetiracetam SUN oral anvendelse.
English: Convulsion, balance disorder, dizziness, lethargy, tremor
Danish: Konvulsioner, balanceforstyrrelse r, svimmelhed, letargi, tremor
English: Talk to your doctor before you are given Levetiracetam SUN - If you suffer from kidney problems, follow your doctor's instructions.
Danish: Kontakt lægen, før De får Levetiracetam SUN - Hvis De lider af nyreproblemer.
English: Dose in adults and adolescents (12 to 17 years) weighing 50 kg or more General dose: between 1,000 mg and 3,000 mg each day.
Danish: Dosis til voksne og unge (12 til 17 år), som vejer 50 kg eller mere Den sædvanlige dosis er mellem 1.000 mg og 3.000 mg dagligt.
English: The total daily dose and frequency of administration should be maintained.
Danish: Den totale daglige dosis og antal indgivelser bør være de sammme.
English: Levetiracetam SUN is used - on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy, to treat a certain form of epilepsy.
Danish: Levetiracetam SUN anvendes - alene (uden andre lægemidler) hos voksne og unge over 16 år med nydiagnosticeret epilepsi til behandling af en bestemt type epilepsi.
English: The maximum dose is 1500 mg twice daily.
Danish: Den maksimale dosis er 1.500 mg to gange dagligt.